Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 31, 2023

Drug Sales Trends for PHENYTOIN EX

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Payment Methods and Pharmacy Types for PHENYTOIN EX (2020)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$17,332,163
INSIDE ANOTHER STORE	$1,866,137
[disabled in preview]	$38,352,157
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	143,224
INSIDE ANOTHER STORE	78,475
[disabled in preview]	866,394
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$736,059
MEDICARE	$19,400,442
[disabled in preview]	$37,413,954
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for PHENYTOIN EX

Drug Units Sold Trends for PHENYTOIN EX

Annual Sales Revenues and Units Sold for PHENYTOIN EX

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Try a Trial
Drug Name	Revenues (USD)	Units	Year
PHENYTOIN EX	⤷ Try a Trial	⤷ Try a Trial	2019
PHENYTOIN EX	⤷ Try a Trial	⤷ Try a Trial	2018
PHENYTOIN EX	⤷ Try a Trial	⤷ Try a Trial	2017
PHENYTOIN EX	⤷ Try a Trial	⤷ Try a Trial	2016
PHENYTOIN EX	⤷ Try a Trial	⤷ Try a Trial	2015
PHENYTOIN EX	⤷ Try a Trial	⤷ Try a Trial	2014
PHENYTOIN EX	⤷ Try a Trial	⤷ Try a Trial	2013
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

Boehringer Ingelheim

Harvard Business School

Mallinckrodt

Dow

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.